Glaxo Report issue

Contributed to NME For profit Phase 3
Founded: Bunnythorpe New Zealand (1873)
Status: Acquired by Glaxo Wellcome (1995)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1984
ranitidine (zantac)
First NDA Approval
1984
ranitidine (zantac)
Last Known Activity
1994

Mergers & Acquisitions

Historical Acquisition Tree